Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
199
Price
$364.83
Total Value
$72.60K
Shares Held After
24,066
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
47
Price
$363.55
Total Value
$17.09K
Shares Held After
24,265
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
73
Price
$362.38
Total Value
$26.45K
Shares Held After
24,312
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
98
Price
$361.45
Total Value
$35.42K
Shares Held After
24,385
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
155
Price
$360.22
Total Value
$55.83K
Shares Held After
24,483
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
85
Price
$359.14
Total Value
$30.53K
Shares Held After
24,638
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
123
Price
$358.18
Total Value
$44.06K
Shares Held After
24,723
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
96
Price
$357.17
Total Value
$34.29K
Shares Held After
24,846
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
41
Price
$356.09
Total Value
$14.60K
Shares Held After
24,942
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
42
Price
$355.16
Total Value
$14.92K
Shares Held After
24,983
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
39
Price
$353.95
Total Value
$13.80K
Shares Held After
25,025
% of Holdings
0.2%
Immuneering Corp (IMRX)
Feinberg Peter — Director
Shares
20,000
Price
$4.35
Total Value
$86.90K
Shares Held After
135,441
% of Holdings
14.8%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
2,900
Price
$27.54
Total Value
$79.87K
Shares Held After
5,602,302
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
7,117
Price
$33.15
Total Value
$235.93K
Shares Held After
639,151
% of Holdings
1.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
9,119
Price
$32.21
Total Value
$293.71K
Shares Held After
646,268
% of Holdings
1.4%
Mineralys Therapeutics, Inc. (MLYS)
Levy Adam Scott — CFO and Secretary
Shares
10,758
Price
$32.14
Total Value
$345.72K
Shares Held After
8,638
% of Holdings
55.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$32.32
Total Value
$205.14K
Shares Held After
61,804
% of Holdings
9.3%
Zymeworks Inc. (ZYME)
Hollywood Mark — EVP & Chief Operating Officer
Shares
6,120
Price
$22.67
Total Value
$138.76K
Shares Held After
132,913
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$479.51
Total Value
$3.78M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14,625
Price
$479.51
Total Value
$7.01M
Shares Held After
0
% of Holdings
100.0%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
13,165
Price
$37.43
Total Value
$492.77K
Shares Held After
140,769
% of Holdings
8.6%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
20,533
Price
$37.43
Total Value
$768.55K
Shares Held After
154,514
% of Holdings
11.7%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
36,932
Price
$37.43
Total Value
$1.38M
Shares Held After
350,919
% of Holdings
9.5%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
13,548
Price
$37.43
Total Value
$507.10K
Shares Held After
184,174
% of Holdings
6.9%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
27,289
Price
$37.43
Total Value
$1.02M
Shares Held After
579,394
% of Holdings
4.5%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
66,610
Price
$37.43
Total Value
$2.49M
Shares Held After
1,037,528
% of Holdings
6.0%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
11,047
Price
$37.43
Total Value
$413.49K
Shares Held After
156,700
% of Holdings
6.6%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
21,142
Price
$37.43
Total Value
$791.35K
Shares Held After
176,883
% of Holdings
10.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
315
Price
$174.86
Total Value
$55.08K
Shares Held After
306,891
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
297
Price
$172.36
Total Value
$51.19K
Shares Held After
307,206
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
297
Price
$171.31
Total Value
$50.88K
Shares Held After
307,503
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
160
Price
$170.24
Total Value
$27.24K
Shares Held After
307,800
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
6,996
Price
$169.57
Total Value
$1.19M
Shares Held After
307,960
% of Holdings
2.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
7,176
Price
$168.63
Total Value
$1.21M
Shares Held After
314,956
% of Holdings
2.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,974
Price
$167.73
Total Value
$666.56K
Shares Held After
322,132
% of Holdings
1.2%
Arcellx, Inc. (ACLX)
Heery Christopher — CHIEF MEDICAL OFFICER
Shares
6,131
Price
$64.15
Total Value
$393.29K
Shares Held After
37,068
% of Holdings
14.2%
Zymeworks Inc. (ZYME)
Smith Jeffrey T L — EVP & Chief Medical Officer
Shares
9,310
Price
$22.67
Total Value
$211.09K
Shares Held After
26,708
% of Holdings
25.8%
Zymeworks Inc. (ZYME)
Moore Paul Andrew — Chief Scientific Officer
Shares
9,560
Price
$22.67
Total Value
$216.76K
Shares Held After
48,497
% of Holdings
16.5%
Aktis Oncology, Inc. (AKTS)
EcoR1 Capital, LLC — Director
Shares
144,443
Price
$18.00
Total Value
$2.60M
Shares Held After
347,305
% of Holdings
41.6%
Aktis Oncology, Inc. (AKTS)
EcoR1 Capital, LLC — Director
Shares
2,077,779
Price
$18.00
Total Value
$37.40M
Shares Held After
4,348,658
% of Holdings
47.8%
Zymeworks Inc. (ZYME)
Galbraith Kenneth — Director
Shares
30,424
Price
$22.67
Total Value
$689.82K
Shares Held After
226,842
% of Holdings
11.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
8,548
Price
$1.71
Total Value
$14.66K
Shares Held After
83,800
% of Holdings
9.3%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
5,388
Price
$1.73
Total Value
$9.31K
Shares Held After
593,510
% of Holdings
0.9%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
1,024
Price
$78.70
Total Value
$80.59K
Shares Held After
80,141
% of Holdings
1.3%
Aktis Oncology, Inc. (AKTS)
Vida Ventures II, LLC — 10% Owner
Shares
22,545
Price
$18.00
Total Value
$405.81K
Shares Held After
157,387
% of Holdings
14.3%
Aktis Oncology, Inc. (AKTS)
Vida Ventures II, LLC — 10% Owner
Shares
812,455
Price
$18.00
Total Value
$14.62M
Shares Held After
5,671,825
% of Holdings
14.3%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
58,980
Price
$0.57
Total Value
$33.62K
Shares Held After
2,309,869
% of Holdings
2.5%
Aktis Oncology, Inc. (AKTS)
Kim Helen Susan — Director
Shares
22,545
Price
$18.00
Total Value
$405.81K
Shares Held After
157,387
% of Holdings
14.3%
Aktis Oncology, Inc. (AKTS)
Kim Helen Susan — Director
Shares
812,455
Price
$18.00
Total Value
$14.62M
Shares Held After
5,671,825
% of Holdings
14.3%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
32,705
Price
$5.50
Total Value
$179.88K
Shares Held After
708,587
% of Holdings
4.4%
Showing 551–600 of 1179 transactions (page 12 of 24)